Ebola Outbreak in DRC Declared Global Health Emergency as Death Toll Reaches 91
May 18, 2026
The World Health Organization (WHO) has declared the latest Ebola outbreak in the Democratic Republic of Congo (DRC) a Public Health Emergency of International Concern (PHEIC), escalating the crisis to its highest alert level. With 91 confirmed deaths and 147 suspected cases reported since the outbreak was first identified in late April, health officials are racing to contain the virus before it spreads beyond the affected regions of North Kivu and Ituri provinces. The declaration marks the 12th Ebola epidemic in DRC since 1976, but the first to be classified as a global emergency since the 2018–2020 West Africa outbreak.
This is not just another Ebola flare-up. The current strain—Sudan ebolavirus—has already demonstrated alarming transmission patterns, including community spread in dense urban areas where previous outbreaks were largely contained in rural settings. The WHO’s decision to invoke the PHEIC protocol reflects growing concerns about the virus’s potential to disrupt regional stability, overwhelm already strained healthcare systems and ignite travel restrictions that could exacerbate economic hardship in Central Africa.
For travelers, health workers, and global policymakers, the stakes could not be higher. The U.S. Centers for Disease Control and Prevention (CDC) has issued a Level 3 Travel Health Notice—recommending travelers avoid nonessential trips to North Kivu and Ituri—while the European Union is preparing contingency plans for potential repatriation of citizens. Meanwhile, the DRC government, with support from the WHO and Médecins Sans Frontières (MSF), is deploying rapid response teams, expanding vaccination rings, and reinforcing border screenings. But with misinformation spreading faster than the virus itself, the real challenge may be trust—both in the medical response and among communities where fear and stigma have historically hindered containment efforts.
Why This Outbreak Demands Global Attention
Unlike previous Ebola epidemics in DRC—which were often confined to remote villages—the current outbreak is unfolding in highly populated and conflict-affected zones. North Kivu and Ituri are home to over 10 million people, including displaced communities and armed groups that complicate health interventions. The WHO’s emergency committee cited “unusual and worrying” transmission patterns, including:
- Urban spread: Cases have been confirmed in Goma, a city of nearly 2 million near the Rwandan border, raising fears of cross-border transmission.
- Healthcare worker infections: At least 17 healthcare workers have contracted Ebola, according to the DRC Ministry of Health, undermining the very system tasked with containment.
- Delayed reporting: Initial cases were not reported until April 28, 2026, nearly a month after symptoms first appeared, allowing the virus to circulate undetected.
The Sudan ebolavirus strain responsible for this outbreak has a case fatality rate of up to 50%—lower than the more infamous Zaire ebolavirus (which caused the 2014–2016 West Africa epidemic and had a fatality rate of ~70%) but still devastating. Symptoms include high fever, severe headache, muscle pain, vomiting, diarrhea, and in later stages, internal and external bleeding. Without rapid access to experimental treatments like REGN-EB3 (a monoclonal antibody cocktail) or supportive care, mortality approaches 90%.
Key Takeaway: The WHO’s PHEIC declaration is not a declaration of panic, but a call to action. It triggers international funding mechanisms, accelerated vaccine distribution, and coordinated global preparedness. For context, the last PHEIC for Ebola was declared in 2019 during the Zaire ebolavirus outbreak in DRC’s eastern provinces, which ultimately killed 2,280 people.
International Efforts to Contain the Virus
The WHO’s emergency declaration has spurred a flurry of activity:
- Vaccination: The DRC has secured 50,000 doses of the Ervebo vaccine (developed by Merck) and is prioritizing ring vaccination—administering the shot to contacts of confirmed cases and their close contacts. Preliminary data suggests the vaccine is 97.5% effective against Zaire ebolavirus, but its efficacy against Sudan ebolavirus is still under study.
- Treatment centers: MSF has opened three Ebola Treatment Centers (ETCs) in Beni, Butembo, and Goma, each with 20–30 isolation beds. The U.S. Has pledged $10 million in emergency funding to support these facilities.
- Travel restrictions: The U.S. Has reinstated Title 42 provisions to limit entry from DRC, while the EU is advising member states to enhance screening at airports. Airlines like Brussels Airlines and Ethiopian Airlines have suspended flights to Goma.
- Misinformation campaigns: The WHO and DRC’s health ministry are partnering with local radio stations to combat rumors, including false claims that Ebola can be cured with “traditional medicines” or that the outbreak is a “foreign conspiracy”.
Challenge: Logistics. Roadblocks, armed groups, and community resistance to vaccination campaigns have delayed responses. In 2018–2020, similar obstacles contributed to 200+ attacks on health workers in DRC’s eastern region. The current outbreak risks repeating those failures if security conditions do not improve.
Ebola 2026: Safety Guidelines for the Public
If you’re planning travel or concerned about exposure, here’s what you need to know:
For Travelers:
- Avoid nonessential travel to North Kivu and Ituri provinces. The CDC’s Level 3 advisory means the risk of Ebola transmission is “high”.
- Check airline policies: Many carriers now require proof of a negative Ebola PCR test for passengers arriving from DRC.
- Monitor symptoms: If you develop fever, severe headache, or unexplained bleeding within 21 days of returning from the region, seek medical attention immediately and inform providers of your travel history.
- No vaccine for travelers: Ervebo is not approved for general use outside high-risk zones, but the CDC is evaluating whether to recommend it for healthcare workers deployed to the region.
For Health Workers:
- PPE protocols: MSF and the WHO emphasize double-gloving, full-body suits, and negative-pressure tents to prevent transmission.
- Psychological support: The emotional toll of Ebola outbreaks is severe. Organizations like Psychologists Without Borders are deploying teams to support frontline workers.
- Experimental treatments: REGN-EB3 and mAb114 (another antibody therapy) are being stockpiled in Goma, but supply is limited.
Myth-Busting: Contrary to social media rumors, Ebola cannot be spread through air, water, or food. Transmission requires direct contact with bodily fluids (blood, vomit, feces) or contaminated surfaces. The virus does not survive long outside the human body.
DRC’s Ebola Epidemics: A Pattern of Crisis
This is the 12th Ebola outbreak in DRC since the virus was first identified in 1976. Yet each epidemic reveals a troubling trend: recurring failures in containment. Here’s how this outbreak compares to past crises:
| Outbreak | Year | Strain | Cases/Deaths | Key Challenge | Global Response |
|---|---|---|---|---|---|
| Yambuku (First Identified) | 1976 | Sudan ebolavirus | 318 cases / 280 deaths | Lack of awareness; limited medical infrastructure | No international intervention |
| Kikwit | 1995 | Zaire ebolavirus | 318 cases / 244 deaths | Delayed response; cultural resistance to burials | WHO deployed teams post-outbreak |
| Bundibugyo | 2007 | Bundibugyo ebolavirus | 149 cases / 128 deaths | Remote location; misdiagnosis | Limited global attention |
| 2018–2020 (North Kivu/Ituri) | 2018–2020 | Zaire ebolavirus | 3,481 cases / 2,280 deaths | Armed conflict; vaccine hesitancy | First PHEIC declaration; widespread vaccination |
| Current Outbreak (2026) | April 2026–present | Sudan ebolavirus | 147+ cases / 91+ deaths (and rising) | Urban spread; healthcare worker infections | Second PHEIC; accelerated vaccine rollout |
Critical Insight: The 2018–2020 outbreak in the same region taught the world two painful lessons: 1) Ebola can persist in “silent” chains of transmission for months, and 2) without trust in the response, containment efforts fail. In 2026, the DRC government and WHO are determined to avoid repeating those mistakes—but the clock is ticking.
Looking Ahead: The Next 30 Days Are Critical
The WHO’s emergency committee has set three urgent priorities for the next month:
- Contain transmission in Goma: The city’s proximity to Rwanda and Uganda makes it a high-risk hub. The WHO aims to vaccinate 90% of contacts within 21 days.
- Secure funding: The outbreak response requires $50 million for the next six months. Donors like the U.S., EU, and Japan have pledged initial sums, but gaps remain.
- Strengthen surveillance: The DRC’s health ministry is deploying rapid diagnostic tests to rural health posts, reducing the time to confirm cases from weeks to days.
Next Checkpoint: The WHO will reconvene its emergency committee on June 1, 2026, to assess progress. In the meantime, the DRC’s health ministry will release a weekly epidemiological update every Friday. For real-time tracking, follow the WHO’s African Regional Office and MSF’s Ebola dashboard.
Call to Action: If you’re a healthcare professional, consider volunteering with organizations like MSF or the International Federation of Red Cross and Red Crescent Societies (IFRC). If you’re a traveler, monitor advisories from the CDC or your national health agency. And if you’re concerned about misinformation, share verified sources—like this article—to counter false claims.
Ebola is a preventable and treatable disease when resources and trust are aligned. The question now is whether the world will act in time.
Frequently Asked Questions About the 2026 Ebola Outbreak
1. Is the Ebola vaccine safe for use against the Sudan ebolavirus strain?
The Ervebo vaccine was developed for Zaire ebolavirus and has shown 97.5% efficacy in clinical trials. However, its effectiveness against Sudan ebolavirus is not yet confirmed. The WHO is conducting real-time efficacy studies in DRC.
2. Can Ebola spread through the air?
No. Ebola is not airborne. Transmission requires direct contact with bodily fluids (blood, vomit, feces) or contaminated surfaces. However, large droplets (e.g., from coughing) can spread the virus over short distances.
3. Are there any approved treatments for Ebola?
Yes. The WHO recommends two experimental treatments:
- REGN-EB3 (monoclonal antibodies by Regeneron)
- mAb114 (developed by the NIH)
Both have shown ~67% survival rates in clinical trials, but supply is limited in DRC.
4. Will this outbreak affect global travel?
Potentially. The U.S. Has already reinstated Title 42 restrictions for DRC travelers, and the EU is considering similar measures. Airlines may suspend flights to high-risk areas, and some countries could impose quarantine requirements for arrivals from affected regions.
5. How can I help?
Donate to verified organizations like:
- Médecins Sans Frontières (MSF)
- International Federation of Red Cross and Red Crescent Societies (IFRC)
- WHO’s Ebola Response Fund
Or volunteer with local health initiatives if you’re in the region.
The 2026 Ebola outbreak in DRC is a stark reminder that global health security is fragile. While the numbers—91 dead, 147 cases—are grim, the response so far offers a glimmer of hope. Vaccines are being deployed faster than ever, international funding is flowing, and communities are being engaged in ways that worked in 2018–2020.
But the window to contain this outbreak is narrow. The next 30 days will determine whether Ebola remains a localized crisis or becomes a regional catastrophe. For now, the world is watching—and acting.
What do you think? Share your concerns, questions, or stories in the comments below. And if you found this report helpful, share it to ensure accurate information reaches those who need it most.